Literature DB >> 7598311

Tamoxifen-induced steatohepatitis.

D S Pratt, T A Knox, J Erban.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7598311     DOI: 10.7326/0003-4819-123-3-199508010-00018

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN: 0003-4819            Impact factor:   25.391


× No keyword cloud information.
  17 in total

Review 1.  Tamoxifen in postmenopausal women a safety perspective.

Authors:  E Robinson; G G Kimmick; H B Muss
Journal:  Drugs Aging       Date:  1996-05       Impact factor: 3.923

Review 2.  Dose adaptation of antineoplastic drugs in patients with liver disease.

Authors:  Lydia Tchambaz; Chantal Schlatter; Max Jakob; Anita Krähenbühl; Peter Wolf; Stephan Krähenbühl
Journal:  Drug Saf       Date:  2006       Impact factor: 5.606

Review 3.  The global NAFLD epidemic.

Authors:  Rohit Loomba; Arun J Sanyal
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2013-09-17       Impact factor: 46.802

Review 4.  Comparative tolerability of first-generation selective estrogen receptor modulators in breast cancer treatment and prevention.

Authors:  M G Curtis
Journal:  Drug Saf       Date:  2001       Impact factor: 5.606

5.  Incidence and risk factors for non-alcoholic steatohepatitis: prospective study of 5408 women enrolled in Italian tamoxifen chemoprevention trial.

Authors:  Savino Bruno; Patrick Maisonneuve; Paola Castellana; Nicole Rotmensz; Sonia Rossi; Marco Maggioni; Marcello Persico; Alberto Colombo; Franco Monasterolo; Donata Casadei-Giunchi; Franco Desiderio; Tommaso Stroffolini; Virgilio Sacchini; Andrea Decensi; Umberto Veronesi
Journal:  BMJ       Date:  2005-03-03

Review 6.  Drug-induced steatohepatitis.

Authors:  Vaishali Patel; Arun J Sanyal
Journal:  Clin Liver Dis       Date:  2013-09-04       Impact factor: 6.126

Review 7.  Efficacy and economics of hormonal therapies for advanced breast cancer.

Authors:  Michael S Simon; Dina Ibrahim; Lisa Newman; Miron Stano
Journal:  Drugs Aging       Date:  2002       Impact factor: 3.923

8.  Pitavastatin ameliorates severe hepatic steatosis in aromatase-deficient (Ar-/-) mice.

Authors:  Tetsu Egawa; Katsumi Toda; Yoshihisa Nemoto; Masafumi Ono; Naoaki Akisaw; Toshiji Saibara; Yoshihiro Hayashi; Makoto Hiroi; Hideaki Enzan; Saburo Onishi
Journal:  Lipids       Date:  2003-05       Impact factor: 1.880

Review 9.  Pathogenesis and management issues for non-alcoholic fatty liver disease.

Authors:  Marko Duvnjak; Ivan Lerotić; Neven Barsić; Vedran Tomasić; Lucija Virović Jukić; Vedran Velagić
Journal:  World J Gastroenterol       Date:  2007-09-14       Impact factor: 5.742

10.  A case-control study of non-alcoholic fatty liver disease in breast cancer.

Authors:  Ahmet Bilici; Mustafa Ozguroglu; Ismail Mihmanli; Hande Turna; Ibrahim Adaletli
Journal:  Med Oncol       Date:  2007       Impact factor: 3.064

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.